# Can you patent a gene?

> Written with AI · [Biotechnology: bioethics and the regulation of research](https://lessoons.com/en/bioethics-and-regulation) · Grade 12 · 2026-11-14 · https://lessoons.com/en/bioethics-and-regulation/can-you-patent-a-gene

In the United States you cannot patent a gene as it occurs in nature, even after isolating it: the Supreme Court ruled so in the Myriad case of 2013, though lab-made cDNA can be patented. In Europe an isolated gene sequence may be patented if the application discloses a real industrial use. Engineered organisms, such as bacteria, can be patented in both; in the US since 1980.

## The topic explained

### What a patent gives, and what it asks

Can you patent a gene? To answer, start with what a patent is: a right, granted by the state, to stop others from making, using or selling an invention, usually for up to 20 years from the date the application was filed. In return the inventor must describe the invention clearly enough for others to repeat it, and when the patent ends anyone may use it. A patent on a process filed in 2005 would therefore end by 2025.

To be granted, an invention must pass three tests: it must be new, it must involve an inventive step, not something obvious to an expert, and it must be useful, with an industrial application. And it must be an invention, not a discovery. A law of nature, a new mineral found in the ground or a plant found in the wild is discovered, not invented. The hard question in biotechnology is where a gene falls on that line. Students often think a patent lets its owner use the invention. In fact it only lets the owner stop others; using it may still need approvals, such as for a medicine.

### Living things become patentable: 1980

In the 1970s Ananda Chakrabarty, working for General Electric, engineered a Pseudomonas bacterium able to break down crude oil, with oil spills in mind. The US patent office refused to patent the bacterium itself because it was alive. In Diamond v. Chakrabarty, decided on June 16, 1980, the Supreme Court ruled 5 to 4 that a living, man-made micro-organism can be patented. What mattered was not whether the thing was alive, but whether it was made by people and differed from anything in nature. The decision opened the way to patents on engineered cells, plants and animals, and with them to the investment that built much of the industry.

### The Myriad case: genes in the United States

The company Myriad Genetics held patents on the human genes BRCA1 and BRCA2 and on tests for variants in them, and it offered testing for these genes exclusively, sending letters that stopped other laboratories. Doctors, researchers and patients sued. On June 13, 2013, in Association for Molecular Pathology v. Myriad Genetics, the Supreme Court ruled unanimously that a naturally occurring DNA segment is a product of nature and cannot be patented merely because it has been isolated. cDNA, the copy made in the laboratory from mRNA without the introns, could be patented, because it does not occur in nature. In 2015 the High Court of Australia reached a similar result on isolated BRCA1 DNA.

Europe draws the line elsewhere. Under the 1998 EU directive and Rule 29 of the European Patent Convention, the human body and the simple discovery of a gene cannot be patented, but a gene sequence isolated by a technical process may be, even if it is identical to the natural one, as long as the application discloses its industrial use. A common misreading is that patents on genes are banned everywhere. The answer depends on the country and on exactly what is claimed.

### Arguments on each side

Supporters of patents in biotechnology argue that developing a test, a medicine or an engineered organism costs years and large sums, and that without a period of exclusive rights few would invest; the patent also forces the invention to be published. Critics argue that a gene belongs to the shared human heritage and that patents on it raised the price of tests, kept patients from second opinions and slowed research by others. Both sides agree that how a claim is worded decides much of the outcome, which is why the debate continues in courts and parliaments.

## Practice: can you patent a gene?

For 12th grade biotechnology students. Answer each question from the sheet, then check your answers.

1. **What right does a patent give its owner, and what must the owner give in return?** — The right to stop others from making, using or selling the invention, usually for up to 20 years from filing. In return the owner must describe the invention publicly, clearly enough for others to repeat it.
2. **Fill in step 3 and name the three tests an invention must pass.** — An examiner checks the tests: the invention must be new, involve an inventive step (not obvious to an expert) and be useful, with an industrial application.
3. **Fill in the event of 1980 and explain why it mattered for biotechnology.** — Diamond v. Chakrabarty: the US Supreme Court ruled 5 to 4 that an engineered, living bacterium can be patented. It opened the way to patents on engineered cells, plants and animals.
4. **Fill in the hidden United States answers and explain the difference between the two rows.** — Isolated gene: no; cDNA: yes. A natural DNA segment is a product of nature even when isolated, while cDNA lacks the introns and does not occur in nature.
5. **Under Rule 29, what must a European application for a gene sequence disclose?** — The industrial application of the sequence, such as its use in a diagnostic test or to make a protein.
6. **A patent application was filed in 2012. Until about what year can the patent last?** — 2012 + 20 = 2032, if the patent is granted and kept in force.
7. **Give one argument for and one against patents on genes, each in a sentence.** — For: exclusive rights repay years of costly development and the invention must be published. Against: genes are shared human heritage, and patents raised test prices and blocked other laboratories.

## Common questions

### Did the Myriad ruling ban all gene patents in the US?

No. It ruled that naturally occurring DNA cannot be patented merely because it was isolated. cDNA, engineered genes, new uses of genes and testing methods can still be patented if they pass the usual tests.

### Can you patent a genetically modified animal or plant?

In the United States, engineered living organisms have been patentable since Diamond v. Chakrabarty in 1980. Europe also allows many such patents but excludes plant and animal varieties as such.

### Is a discovery the same as an invention?

No. A discovery reveals something that already exists, such as a natural gene or a law of nature. An invention is something people made, such as an engineered bacterium or a new test, and only an invention can be patented.

### How long does a patent last?

Usually up to 20 years from the date the application was filed, as long as the owner pays the renewal fees. After that, anyone may use the invention.

### Why does Europe treat isolated genes differently from the US?

European law, through the 1998 EU directive and Rule 29, treats a gene isolated by a technical process as a possible invention if its industrial use is disclosed. The US Supreme Court held in 2013 that isolation alone does not make natural DNA an invention.
